Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

20.57
-0.9300-4.33%
Post-market: 20.570.00000.00%16:34 EDT
Volume:154.08K
Turnover:3.18M
Market Cap:1.39B
PE:-19.05
High:21.62
Open:21.60
Low:20.23
Close:21.50
52wk High:26.30
52wk Low:12.56
Shares:67.77M
Float Shares:17.44M
Volume Ratio:0.66
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0799
EPS(LYR):-1.0800
ROE:-74.45%
ROA:-42.37%
PB:17.28
PE(LYR):-19.05

Loading ...

Pulse Biosciences Grants RSUs to Chief Technology Officer

TIPRANKS
·
9 hours ago

Pulse Biosciences awards CTO Darrin R. Uecker 100,000 restricted stock units; grant vests in full on third anniversary

Reuters
·
11 hours ago

Assessing Pulse Biosciences (PLSE) Valuation After The nPulse Cardiac Catheter Ablation Pivot

Simply Wall St.
·
Mar 23

BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data

Reuters
·
Mar 17

Pulse Biosciences prioritizes R&D and clinical investment for its nPulse cardiac catheter pivotal IDE studies in the US and Europe

Reuters
·
Mar 17

Pulse Biosciences enrolls first patients in 30-person feasibility study of nPulse Vybrance system for papillary thyroid microcarcinoma

Reuters
·
Mar 12

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors With Npulse™ Technology

THOMSON REUTERS
·
Mar 12

Pulse Biosciences Earnings Call: Data Strength Vs. Cash Burn

TIPRANKS
·
Mar 10

Pulse Biosciences Reports Durable Thyroid Nodule Ablation Results

TIPRANKS
·
Mar 09

Pulse Biosciences Announces Clinical Data From Npulse™ Vybrance™ System First-in-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

THOMSON REUTERS
·
Mar 09

Pulse Biosciences to Present at Oppenheimer Annual Healthcare MedTech & Services Conference

Reuters
·
Mar 05

Pulse Biosciences to Showcase nPulse Vybrance System at North American Society for Interventional Thyroidology Annual Meeting

Reuters
·
Mar 04

Pulse Biosciences Highlights nPulse Cardiac Ablation Progress

TIPRANKS
·
Mar 04

Pulse Biosciences Files Amended 8-K to Remove Two Sentences

Reuters
·
Mar 02

Pulse Biosciences (PLSE) Is Down 12.6% After Wider Losses And New Funding Plans - Has The Bull Case Changed?

Simply Wall St.
·
Feb 28

Pulse Biosciences Announces Resignation of Chief Commercial Officer

TIPRANKS
·
Feb 28

Pulse Biosciences Chief Commercial Officer Kevin P. Danahy Resigns Immediately

Reuters
·
Feb 28

Pulse Biosciences Chief Commercial Officer Kevin Patrick Danahy Disposes of Common Shares

Reuters
·
Feb 24

Pulse Biosciences Grants 19,000 Inducement Stock Options to New Hires

Reuters
·
Feb 21

Stock Track | Pulse Biosciences Plummets 5.06% Intraday as Profit-Taking Follows Strong Quarterly Gains Despite Earnings Beat

Stock Track
·
Feb 20